NJ STATE EMPLOYEES DEFERRED COMPENSATION PLAN – Halozyme Therapeutics, Inc. Transaction History
NJ STATE EMPLOYEES DEFERRED COMPENSATION PLAN portfolio value:
$1.09M
portfolio value
NJ STATE EMPLOYEES DEFERRED COMPENSATION PLAN quarter portfolio value change:
-10.14%
quarter
Halozyme Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | -124K | $39.54 | 27.8K | |
| Q2 2022 | share | 0.00% | 0 shares | 115K | $44 | 27.8K | |
| Q1 2022 | share | 0.00% | 0 shares | -10K | $39.88 | 27.8K | |
| Q4 2021 | share | 0.00% | 0 shares | -13K | $40.32 | 27.8K | |
| Q3 2021 | share | 0.00% | 0 shares | -131K | $40.68 | 27.8K | |
| Q2 2021 | share | 0.00% | 0 shares | 103K | $45.41 | 27.8K | |
| Q1 2021 | share | 0.00% | 0 shares | -28K | $41.69 | 27.8K | |
| Q4 2020 | share | 0.00% | 0 shares | 456K | $42.71 | 27.8K | |
| Q3 2020 | share | 0.00% | 0 shares | -14K | $26.28 | 27.8K | |
| Q2 2020 | share | 0.00% | 0 shares | 245K | $26.81 | 27.8K | |
| Q1 2020 | share | 0.00% | 0 shares | 7K | $17.99 | 27.8K | |
| Q4 2019 | share | Increase | +20.87% | 4.8K shares | 136K | $17.73 | 27.8K |
| Q3 2019 | share | 0.00% | 0 shares | -38K | $15.51 | 23K | |
| Q2 2019 | share | 0.00% | 0 shares | 24K | $17.18 | 23K | |
| Q1 2019 | share | Increase | +35.29% | 6K shares | 122K | $16.1 | 23K |
| Q4 2018 | share | Decrease | -37.04% | -10K shares | -242K | $14.63 | 17K |
| Q3 2018 | share | Decrease | -15.63% | -5K shares | -49K | $18.17 | 27K |
| Q2 2018 | share | Decrease | -8.57% | -3K shares | -146K | $16.87 | 32K |
| Q1 2018 | share | Decrease | -12.50% | -5K shares | -124K | $19.59 | 35K |
| Q4 2017 | share | Decrease | -20.00% | -10K shares | -59K | $20.26 | 40K |
| Q3 2017 | share | Decrease | -65.52% | -95K shares | -990K | $17.37 | 50K |
| Q2 2017 | share | 0.00% | 0 shares | -20K | $12.82 | 145K | |
| Q1 2017 | share | 0.00% | 0 shares | 446K | $12.96 | 145K | |
| Q4 2016 | share | 0.00% | 0 shares | -319K | $9.88 | 145K | |
| Q3 2016 | share | 0.00% | 0 shares | 501K | $12.08 | 145K | |
| Q2 2016 | share | 0.00% | 0 shares | -350K | $8.63 | 145K | |
| Q1 2016 | share | 0.00% | 0 shares | -912K | $9.47 | 145K |